期刊文献+

曲克芦丁微乳的处方筛选及含量测定 被引量:2

Formulation Screening and Determination of Troxerutin Microemulsion
下载PDF
导出
摘要 目的筛选亲水性药物曲克芦丁油包水型口服微乳的最佳处方,考察其形态、粒径大小、稳定性,并建立其含量测定方法。方法利用伪三元相图,以微乳形成区域大小为指标,筛选制备微乳的最佳处方。采用高效液相色谱法测定微乳中药物含量。结果筛选出的最佳处方是大豆磷脂/无水乙醇/肉豆蔻酸异丙酯/纯化水=23.30∶11.67∶52.45∶12.59。所制得的微乳外观圆整,大小分布均匀,平均粒径为50.20 nm,具有良好稳定性。结论大豆磷脂/无水乙醇/肉豆蔻酸异丙酯/纯化水体系将曲克芦丁成功包载于水相,有望为曲克芦丁口服给药提供一种有效的新剂型。 Objective To optimize a W / O microemulsion formulation of troxerutin and evaluate its physical properties such as morphology,droplet size,stability and content of troxerutin. Methods The W / O microemulsion was optimized using a pseudoternary phase diagram and the area of the microemulsion region was used to screen and determine microemulsion components.HPLC assay was used for determination of the loading content. Results The optimal formulation contained lecithin,ethanol,isopropyl myristate and water( 23. 30 ∶ 11. 67 ∶ 52. 45 ∶ 12. 59). The microemulsion was physicochemically stable with round shape and uniform size,and the mean droplet size was about 50. 20 nm. Conclusion Microemulsion was developed successfully.It will expect to be the new preparation for troxerutin.
出处 《医药导报》 CAS 2015年第12期1627-1632,共6页 Herald of Medicine
基金 安徽省高校自然科学基金重点项目(KJ2013A153)
关键词 曲克芦丁 伪三元相图 微乳 质量评价 Troxerutin Pseudoternary phase diagram Microemulsion Quality evaluation
  • 相关文献

参考文献8

  • 1付远清.曲克芦丁的药理性质及临床应用概况[J].中国医药指南,2012,10(7):59-60. 被引量:15
  • 2LIU F, XU Y, RUI L, et al. Liquid chromatography/tandem mass spectrometry assay for the quantification of troxerutin in human plasma [ J ]. Rapid Commun Mass Spectrom, 2006,20 (23) : 3522-3526.
  • 3CUI X Y, ZHANG M L, GUAN X, et al. LC-MS-MS deter- mination of troxerutin in plasma and its application to a pharmacokinetic study [ J ]. Chromatographia, 2011,73 : 165 - 169.
  • 4LI Y, SONG J, TIAN N, et al.Improving oral bioavailability of metformin hydrochloride using water-in-oil microemulsions and analysis of phase behavior after dilution [ J ]. Int J Pharm, 2014,473(1-2) :316-325.
  • 5李磊,王长远,蔡芸,高鹏程,田燕,刘克辛.羟丝肽口服微乳的制备与体内药动学研究[J].医药导报,2014,33(2):135-139. 被引量:2
  • 6LIN C C, LIN H Y, CHI M H, et al. Preparation of curcumin microemulsions with food-grade soybean oil/lecithin and their cytotoxicity on the HepG2 cell line [ J ]. Food Chem, 2014, 154 : 282- 290.
  • 7LEE P J, LANGER R, SHASTRI V P. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs [ J ] .Pharm Res, 2003,20 (2) :264-269.
  • 8TANG T T, HU X B, LIAO D H, et al. Mechanisms of micro- emulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach [ J ]. Int J Nanomedicine, 013,8 : 4415 - 4426.

二级参考文献27

  • 1张晨峥,毛甜甜,姜鸣,叶惟虎,胡璇,敖英,汪晖.曲克芦丁的镇痛作用研究[J].医学新知,2005,15(3):31-32. 被引量:4
  • 2齐贵胜,裴素霞,任家胜.曲克芦丁对四氯化碳致小鼠实验性肝损伤的保护作用[J].中医药学刊,2006,24(8):1539-1540. 被引量:8
  • 3Unkauf M,Rehn D,klinger J,et al.Investigation of the efficacy of oxenrutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings[J].Arzneimittelf orschung,1996,46(3):478-482.
  • 4Rehn D,Brunnauer H,Diebschlag W,et al.Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration[J].Arzneimittelforschung,1996,46(3):488-492.
  • 5Wadworth AN,Faulds D.Hydroxyethylrutosides.A review of its pharmacology,and therapeutic efficacyin venous insufficiency and related disorders[J].Drugs,1992,44(8):1013-1033.
  • 6Cesarone MR,Belcaro G,Brandolini R,et al.The lonflit4-Venorutin Study:a randomized trial—prophylaxis of flight-edema in venous patients[J].Angiology,2003,54(2):137-142.
  • 7Belcaro G,Cesarone MR,Nicolaides AN,et al.The lonflit4-Venorutin Study:a randomized trial—prophylaxis of flight-edema in normal subjects[J].Clin Appl Thromb Hemost,2003,9(1):19-23.
  • 8Wijayanegara H,Mose JC,Achmad L,et al.A clinical trial of hydroxyethylrutosides in the treatment of hemorrhoids of pregnancy[J].J Int Med Res,1992,20(1):54-60.
  • 9印晓星,扬帆.生物药剂学与药物动力学[M].北京:科学出版社,2009:180-195.
  • 10LIU K X,KATO Y,KAKU T,et al. Hydroxyprolylserinederivatives JBP923 and JBP 485 exhibit the antihepatitisactivities after gastrointestinal absorption in rats [ J]. JPharm Exp Ther,2000,294(2):510-515.

共引文献15

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部